Greetings from C-IP2 Interim Executive Director Joshua A. KreshI am happy to provide our first progress report since I took over on May 25th as Interim Executive Director following Professor Seán O’Connor’s return to full-time research and teaching. Read more
After successfully steering Scalia Law’s Center for Intellectual Property x Innovation Policy (C-IP2) through a rebranding and expansion that resulted in a Top 20 ranking for the Law School’s IP Program, Professor Seán O’Connor is returning to full time research and teaching. Read more
By Jack Ring
In their forthcoming paper, Solutions Still Searching for a Problem: A Call for Relevant Data to Support “Evergreening” Allegations,[1] C-IP2 Senior Scholars Erika Lietzan of Mizzou Law and Kristina Acri of Colorado College call for relevant data to support evergreening allegations and accompanying policy proposals. Read more
By Jason Lee Guthrie
For the Center for Intellectual Property x Innovation Policy blog, in fulfillment of obligations for the Thomas Edison Innovation Law and Policy Fellowship
In early 1940, Woody Guthrie was on the road to New York City, and he was tired. Read more
Courts have recently questioned Food and Drug Administration (FDA) determinations. The FDA is the administrative agency whose job is to evaluate scientific data to determine if a drug is safe and effective enough to be approved, and post-approval, to continue to evaluate such data to determine if a drug should remain available. Read more
On Friday the Federal Court for the Southern District of New York (SDNY) ruled in favor of Hachette and other major book publishers, and against Internet Archive (IA) in a lawsuit considering IA’s Controlled Digital Lending (CDL) program, under which IA scanned books and “loaned” digital copies of copyrighted works over the internet. Read more
Greetings from C-IP2 Faculty Director Seán O’ConnorWith this Spring 2023 Progress Report, we’re pleased to provide you with updates on what C-IP2 and our friends and affiliates have been working on from December 2022 through February 2023, from academic roundtables and other events to publications and various engagements. Read more
Greetings from C-IP2 Faculty Director Seán O’ConnorWith warmest wishes for the holiday season, we present our last report of 2022. This has been the year in which many of our programs were held in person again. We are grateful to our community for supporting the transition back to in-person events. Read more
This policy brief, including the following “Introduction and Executive Summary,” comes from Eric M. Solovy.
CLICK HERE to read the brief in full.
Introduction and Executive Summary
On June 17, 2022, in the early morning hours of the final day of the World Trade Organization’s (“WTO”) 12th Ministerial Conference, the Members of the WTO adopted a waiver of the Agreement on Trade Related Aspects of Intellectual Property Rights (“the TRIPS Agreement”), commonly known as the “TRIPS Waiver for COVID-19 Vaccines” or the “TRIPS Waiver.” Read more
Will Donald Trump’s lawsuit against Bob Woodward and publisher Simon & Schuster